Infectious Disease
Epstein Barr Virus
0
Pipeline Programs↗
13
Active Trials↗
2
Companies Involved↗
Epstein Barr Virus is an early-stage landscape with 0 programs across 2 companies. The most active players are Moderna, Atara Biotherapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
24
clinical trials
Completed6 · 25%
Active, not recruiting5 · 21%
Recruiting5 · 21%
Unknown status4 · 17%
Not yet recruiting2 · 8%
No longer available1 · 4%
Other1 · 4%
Clinical Trials
Trial Activity
24 trials
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Recruiting·—·Phase 1/2·NCT06909110·25 enrolled
Genetic Studies of Chronic Active Epstein-Barr Virus Infection
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00032513·300 enrolled
Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection
Active, not recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT04645147·83 enrolled
Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
Active, not recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1/2·NCT05683834·25 enrolled
L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
Not yet recruiting·—·Phase 3·NCT05775705·25 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)